Search

Search Constraints

You searched for: Author/Creator Langleben, David

Search Results

1. Anatomical Considerations for the Development of a New Transcatheter Aortopulmonary Shunt Device in Patients with Severe Pulmonary Arterial Hypertension. (1st September 2013)

2. Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study. (December 2020)

3. Assessment of the REPLACE study composite endpoint in riociguat‐treated patients in the PATENT study. (1st December 2020)

4. Canadian Cardiovascular Society and Canadian Thoracic Society Position Statement on Pulmonary Arterial Hypertension. Issue 6 (3rd September 2005)

6. Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies). (1st July 2020)

7. Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies). (July 2020)

9. Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE. (15th October 2020)

10. Impact of saline loading at cardiac catheterization on the classification and management of patients evaluated for pulmonary hypertension. (1st May 2020)